Nanoemulsion Market

Global Nanoemulsion Market Size, Share & Trends Analysis Report by Drug Class (Steroids, Anesthetics, Antibiotics, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Immunosuppressant, and Others), By Route of Administration (Oral, Parenteral, and Others), and Forecast 2019-2025
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2022132 | Category : Pharmaceuticals | Delivery Format: /

The global Nanoemulsion market is projected to grow at a significant CAGR during the forecast period. The upgradations in the techniques for the delivery of the drug led to the advent of nanoemulsion. It is an Isotropic mixture of oil, surfactant, water, and drug.  Nanoemulsion in the field of drug delivery system improves the therapeutic and pharmacological action of a drug as well as eliminates the adverse effect or toxic reactions of drugs. The key application of nanoemulsion include the treatment of the reticuloendothelial system, enzyme replacement therapy in the liver, tyrosine kinase inhibitor, epidermal growth factor inhibitor in lungs; treatment of various cancers such as brain, lungs, colon, ovarian, breast, blood cancer and their vaccination.

The key factors that drive the growth of the market include the enhancements in the pharmaceutical and biotechnology industry, rising cases of chronic diseases, rising awareness among the peoples for the treatments of chronic disease, growing demand for more target-specific drug delivery systems, and supportive policies of governments. Further, the various benefits offered by nanoemulsion such as improved water solubility of poorly water-soluble drugs, ability to make plasma concentration of drug profiles, more reproducible bioavailability of drugs, various routes of administration of the drug, effective drug transport system, and others are also fueling the market growth. However, lack of awareness might act as a challenging factor of the global nanoemulsion market during the forecast period.

Segmental Outlook

The global Nanoemulsion market is segmented on the basis of drug class and route of administration. Based on the drug class, the market has been segmented into steroids, anesthetics, antibiotics, nonsteroidal anti-inflammatory drugs (NSAIDs), immunosuppressant, and others including antimicrobials, antiretroviral, vasodilators. Based on the route of administration, the market is segmented into oral, parenteral, and others including nasal. 

Amongst the drug class of the global nanoemulsion market, nonsteroidal anti-inflammatory drugs (NSAIDS) segment is estimated to hold a significant share in the market during the forecast period. The segmental share is attributed to the increased utilization of this nanoemulsion formulation in the administration of topical and other drug routes for effective drug delivery and rapid penetration. In addition, antibodies are also likely to hold significant share owing to the increased interests of the players, as the rising antibiotic resistance has received increased attention from researchers and several companies.

Regional Outlook

The global Nanoemulsion market is geographically segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to hold a significant share in the global market during the forecast period. This is attributed to the rising incidences of chronic diseases. Further, the pre3sence of well-developed healthcare infrastructure, rising economic stability, and increasing participation of major market players in the region are propelling the nanoemulsion industry growth during the forecast period. Further, the Rest of the World is also expected to register significant growth owing to the governments’ initiatives to encourage pharmaceutical and healthcare businesses and the rising healthcare expenditure in areas such as Latin America and the Middle East and Africa.

Global Nanoemulsion Market by Region, 2018 (%)

Market Players Outlook

The global nanoemulsion market is overall consolidated, that is, having a specific number of companies operating. Some of the players operating in the global nanoemulsion market include Allergan Plc, NanoBio Corp., Latitude Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd., and Taiwan Liposome Co. Ltd. These are the key companies adopting several organic and inorganic growth strategies such as product launches & developments, partnerships, agreements, and acquisitions to strengthen their product portfolios and maintain a competitive position in the global nanoemulsion market. 

The Report Covers

  • Market value data analysis of 2018 and forecast to 2025.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global Nanoemulsion market. Based on the availability of data, information related to products, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying ‘who-stands-where’ in the market.

1. Report Summary

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

1.2.2. By Geography

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

2.3. Rules & Regulations

3. Competitive Landscape

3.1. Key Strategy Analysis

3.2. Key Company Analysis

3.2.1. Overview

3.2.2. Financial Analysis 

3.2.3. SWOT Analysis

3.2.4. Recent Developments

4. Market Determinants

4.1. Motivators

4.2. Restraints

4.3. Opportunities

5. Market Segmentation

5.1. Global Nanoemulsion Market by Drug Class

5.1.1. Steroids

5.1.2. Anesthetics

5.1.3. Antibiotics

5.1.4. Nonsteroidal Anti-inflammatory drugs (NSAIDs)

5.1.5. Immunosuppressant

5.1.6. Others (Antimicrobials)

5.2. Global Nanoemulsion Market by Route of Administration

5.2.1. Oral

5.2.2. Parenteral

5.2.3. Others (Nasal)

6. Regional Analysis

6.1. North America

6.1.1. United States

6.1.2. Canada

6.2. Europe

6.2.1. UK

6.2.2. Germany

6.2.3. Italy

6.2.4. Spain

6.2.5. France

6.2.6. Rest of Europe 

6.3. Asia-Pacific

6.3.1. China

6.3.2. India

6.3.3. Japan

6.3.4. Rest of Asia-Pacific 

6.4. Rest of the World

7. Company Profiles

7.1. Allergan PLC

7.2. Ascendia Pharmaceuticals

7.3. Covaris Inc.

7.4. Foamix Ltd.

7.5. Latitude Pharmaceuticals Inc.

7.6. Microfluidics, aIDEX Corp. company 

7.7. NanoBio Corp.

7.8. Nanogen Labs, Inc.

7.9. Santen Pharmaceutical Co., Ltd.

7.10.  Taiwan Liposome Co. Ltd.

1. GLOBAL NANOEMULSION MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2018-2025 ($ MILLION)

2. GLOBAL STEROIDS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

3. GLOBAL ANESTHETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

4. GLOBAL ANTIBIOTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

5. GLOBAL NON STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

6. GLOBAL IMMUNO SUPPRESSANT MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

7. GLOBAL OTHER DRUG CLASS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

8. GLOBAL NANOEMULSION MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2018-2025 ($ MILLION)

9. GLOBAL NANOEMULSION FOR ORAL ADMINISTRATION MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

10. GLOBAL NANOEMULSION FOR PARENTERAL ADMINISTRATION MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

11. GLOBAL NANOEMULSION FOR OTHER ROUTE OF ADMINISTRATION MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

12. GLOBAL NANOEMULSION MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)

13. NORTH AMERICAN NANOEMULSION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

14. NORTH AMERICAN NANOEMULSION MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2018-2025 ($ MILLION)

15. NORTH AMERICAN NANOEMULSION MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2018-2025 ($ MILLION)

16. EUROPEAN NANOEMULSION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

17. EUROPEAN NANOEMULSION MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2018-2025 ($ MILLION)

18. EUROPEAN NANOEMULSION MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2018-2025 ($ MILLION)

19. ASIA-PACIFIC NANOEMULSION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

20. ASIA-PACIFIC NANOEMULSION MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2018-2025 ($ MILLION)

21. ASIA-PACIFIC NANOEMULSION MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2018-2025 ($ MILLION)

22. REST OF THE WORLD NANOEMULSION MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2018-2025 ($ MILLION)

23. REST OF THE WORLD NANOEMULSION MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2018-2025 ($ MILLION)

1. GLOBAL NANOEMULSION MARKET SHARE BY DRUG CLASS, 2018 VS 2025 (%)

2. GLOBAL NANOEMULSION MARKET SHARE BY ROUTE OF ADMINISTRATION, 2018 VS 2025 (%)

3. GLOBAL NANOEMULSION MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)

4. US NANOEMULSION MARKET SIZE, 2018-2025 ($ MILLION)

5. CANADA NANOEMULSION MARKET SIZE, 2018-2025 ($ MILLION)

6. UK NANOEMULSION MARKET SIZE, 2018-2025 ($ MILLION)

7. FRANCE NANOEMULSION MARKET SIZE, 2018-2025 ($ MILLION)

8. GERMANY NANOEMULSION MARKET SIZE, 2018-2025 ($ MILLION)

9. ITALY NANOEMULSION MARKET SIZE, 2018-2025 ($ MILLION)

10. SPAIN NANOEMULSION MARKET SIZE, 2018-2025 ($ MILLION)

11. ROE NANOEMULSION MARKET SIZE, 2018-2025 ($ MILLION)

12. INDIA NANOEMULSION MARKET SIZE, 2018-2025 ($ MILLION)

13. CHINA NANOEMULSION MARKET SIZE, 2018-2025 ($ MILLION)

14. JAPAN NANOEMULSION MARKET SIZE, 2018-2025 ($ MILLION)

15. REST OF ASIA-PACIFIC NANOEMULSION MARKET SIZE, 2018-2025 ($ MILLION)

16. REST OF THE WORLD NANOEMULSION MARKET SIZE, 2018-2025 ($ MILLION)